Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
RESEARCH TOOLSreports
Tarsus Pharmaceuticals (TARS) Stock Price & Analysis
118 Followers
TARS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.33 - $25.25
Previous Close$17.29
Volume418.58K
Average Volume (3M)546.42K
Market Cap
$566.75M
Enterprise Value$349.57M
Total Cash (Recent Filing)$246.88M
Total Debt (Recent Filing)$29.71M
Price to Earnings (P/E)-4.5
Beta0.71
Next Earnings
Mar 11, 2024EPS Estimate
-$1.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.83
Shares Outstanding33,104,612
10 Day Avg. Volume593,715
30 Day Avg. Volume546,425
Standard Deviation0.18
R-Squared0.06
Alpha-0.00028
Financial Highlights & Ratios
Price to Book (P/B)2.57
Price to Sales (P/S)21.95
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue24.32
Enterprise Value/Gross Profit14.35
Enterprise Value/Ebitda-4.80
Forecast
1Y Price Target
$46.50Price Target Upside168.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Tarsus Pharmaceuticals News
Ownership Overview
0.00% Insiders
9.09% Mutual Funds
69.18% Other Institutional Investors
21.73% Public Companies and
Individual Investors
TARS FAQ
What was Tarsus Pharmaceuticals’s price range in the past 12 months?
Tarsus Pharmaceuticals lowest stock price was $11.33 and its highest was $25.25 in the past 12 months.
What is Tarsus Pharmaceuticals’s market cap?
Currently, no data Available
When is Tarsus Pharmaceuticals’s upcoming earnings report date?
Tarsus Pharmaceuticals’s upcoming earnings report date is Mar 11, 2024 which is in 92 days.
How were Tarsus Pharmaceuticals’s earnings last quarter?
Tarsus Pharmaceuticals released its earnings results on Nov 09, 2023. The company reported -$1.28 earnings per share for the quarter, beating the consensus estimate of -$1.35 by $0.07.
Is Tarsus Pharmaceuticals overvalued?
According to Wall Street analysts Tarsus Pharmaceuticals’s price is currently Undervalued.
Does Tarsus Pharmaceuticals pay dividends?
Tarsus Pharmaceuticals does not currently pay dividends.
What is Tarsus Pharmaceuticals’s EPS estimate?
Tarsus Pharmaceuticals’s EPS estimate is -$1.37.
How many shares outstanding does Tarsus Pharmaceuticals have?
Tarsus Pharmaceuticals has 33,104,610 shares outstanding.
What happened to Tarsus Pharmaceuticals’s price movement after its last earnings report?
Tarsus Pharmaceuticals reported an EPS of -$1.28 in its last earnings report, beating expectations of -$1.35. Following the earnings report the stock price went up 12.203%.
Which hedge fund is a major shareholder of Tarsus Pharmaceuticals?
Among the largest hedge funds holding Tarsus Pharmaceuticals’s share is Perceptive Advisors LLC. It holds Tarsus Pharmaceuticals’s shares valued at 23M.
---
Tarsus Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$46.50 (168.94% Upside)
$46.50 (168.94% Upside)
Blogger Sentiment
Bullish
TARS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 754.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.94%
12-Months-Change
Fundamentals
Return on Equity
-51.69%
Trailing 12-Months
Asset Growth
13.48%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.
---
Top 5 ETFs holding TARS
Vanguard Total Stock Market ETF
$12.98M
Vanguard Health Care ETF
$1.11M
Schwab U.S. Broad Market ETF
$272.87K
iShares Russell 3000 ETF
$52.66K
Vanguard Russell 3000 ETF
$20.41K
Up to five ETFs with an Outperform Smart Score that hold TARS. The ETFs are listed according to market value of TARS within the ETF
---